Cargando…
The systematic development of attributes and levels for a discrete choice experiment of HIV patient preferences for long-acting antiretroviral therapies in the United States
INTRODUCTION: Patient preferences for long-acting antiretroviral therapies (LA-ART) should inform development of regimens with optimal adherence and acceptability. We describe a systematic process used to identify attributes and levels for a discrete choice experiment (DCE) designed to elicit prefer...
Autores principales: | Brah, Aaron T., Barthold, Douglas, Hauber, Brett, Collier, Ann C., Ho, Rodney J. Y., Marconi, Vincent C., Simoni, Jane M., Graham, Susan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881811/ https://www.ncbi.nlm.nih.gov/pubmed/35216610 http://dx.doi.org/10.1186/s12981-022-00435-6 |
Ejemplares similares
-
U.S. patient preferences for long‐acting HIV treatment: a discrete choice experiment
por: Graham, Susan M., et al.
Publicado: (2023) -
Improvements to Survey Design from Pilot Testing a Discrete-Choice Experiment of the Preferences of Persons Living with HIV for Long-Acting Antiretroviral Therapies
por: Barthold, Douglas, et al.
Publicado: (2022) -
Preference for daily oral pills over long-acting antiretroviral therapy options among people with HIV
por: Barthold, Douglas, et al.
Publicado: (2023) -
Qualitative Assessment of the Application of a Discrete Choice Experiment With Community Health Workers in Uganda: Aligning Incentives With Preferences
por: Brunie, Aurélie, et al.
Publicado: (2016) -
Preferences of People Living with HIV for Long-Acting Antiretroviral Treatment in Germany: Evidence from a Discrete Choice Experiment
por: Emmert, Martin, et al.
Publicado: (2023)